Projects per year
Personal profile
Education
- 2007-2013 Ph.D., Institute of Bioinformatics and Biosignal Transduction, National Cheng Kung University
- 2005-2007 M.S., Department of Pharmacology, National Cheng Kung University
- 2007-2005 B.S., School of Pharmacy, Kaohsiung Medical University
Experience
- 2024.08- Associate Professor, School of Respiratory Therapy, College of Medicine, Taipei Medical University
- 2019.08- Assistant Professor, School of Respiratory Therapy, College of Medicine, Taipei Medical University
- 2020.08-2021.07 Visiting Scholar, Cardiovascular Research Institute, University of California, San Francisco, USA
- 2014.08-2019.07 Postdoctoral Research Fellow, Department of Biotechnology and Bioindustry Sciences, National Cheng Kung University
- 2013.08-2014.07 Pharmacist
- 2011.10-2012.10 Special Volunteer, National Institute on Drug Abuse, National Institutes of Health, U.S.A
Research Interests
- Respiratory Pharmacology
- Lung Cancer Mechanism
- Drug Development
Fingerprint
Dive into the research topics where Shao-An Wang is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
To Study the Role of Usp24 and Usp7 on Cancer Metabolism in Lung Cancer( I )
Wang, S.-A. (PI)
8/1/25 → 7/31/26
Project: A - Government Institution › b - National Science and Technology Council
-
To study the role and therapeutic strategy in USP24-mediated gender- dependent pulmonary fibrosis progression
Wang, S.-A. (PI)
7/1/25 → 2/28/26
Project: A - Government Institution › b - National Science and Technology Council
-
Investigating the Role and Mechanism of Usp24 on Pulmonary Fibrosis
Wang, S.-A. (PI)
8/1/24 → 7/31/25
Project: A - Government Institution › b - National Science and Technology Council
-
To investigate the role of USP24 on mitochondrial function in drug- resistant lung cancer
Wang, S.-A. (PI)
7/1/24 → 2/28/25
Project: A - Government Institution › b - National Science and Technology Council
-
To Investigate the Role of Usp24 Inhibitor Targeting Ferroptosis as a Potential Therapeutic Approach for Therapy-Resistant Cancers and Fibrosis
Wang, S.-A. (PI)
8/1/23 → 7/31/24
Project: A - Government Institution › b - National Science and Technology Council
Research output
- 21 Article
-
DSG2 attenuates gemcitabine efficacy through PTX3 in lung adenocarcinoma
Wang, C. C., Lin, J. Y., Wang, C. Y., Shen, W. J., Liao, P. C., Ho, Y. F., Lin, C. W., Wang, S. A., Ko, C. C., Dey, S., Ta, H. D. K., Xuan, D. T. M., Kumar, S., William, B. T., Wang, J. M. & Wang, W. J., Aug 2025, In: Biochimica et Biophysica Acta - Molecular Basis of Disease. 1871, 6, p. 167881 167881.Research output: Contribution to journal › Article › peer-review
-
USP24 upregulation stabilizes PKA-Cα to promote lipogenesis, inflammation, and fibrosis during MASH progression
Ning, B., Wang, S. A., Young, M. J., Chen, Y. C., Hung, Y., Huong, T. T., Chang, W. C., Wang, Y. C., Yu, M. L., Hsu, K. C. & Hung, J. J., Dec 2025, In: Journal of Biomedical Science. 32, 1, 54.Research output: Contribution to journal › Article › peer-review
Open Access2 Citations (Scopus) -
First-in-Class Dual EZH2-HSP90 Inhibitor Eliciting Striking Antiglioblastoma Activity In Vitro and In Vivo
Sharma, S., Wang, S. A., Yang, W. B., Lin, H. Y., Lai, M. J., Chen, H. C., Kao, T. Y., Hsu, F. L., Nepali, K., Hsu, T. I. & Liou, J. P., Feb 22 2024, In: Journal of Medicinal Chemistry. 67, 4, p. 2963-2985 23 p.Research output: Contribution to journal › Article › peer-review
Open Access6 Citations (Scopus) -
NCI677397 targeting USP24-mediated induction of lipid peroxidation induces ferroptosis in drug-resistant cancer cells
Wang, S. A., Wu, Y. C., Yang, F. M., Hsu, F. L., Zhang, K. & Hung, J. J., 2024, In: Molecular Oncology. 18, 9, p. 2255-2276 22 p.Research output: Contribution to journal › Article › peer-review
Open Access14 Citations (Scopus) -
Neutralization of CX3CL1 Attenuates TGF-β-Induced Fibroblast Differentiation Through NF-κB Activation and Mitochondrial Dysfunction in Airway Fibrosis
Cheng, W. H., Chang, P. L., Wu, Y. C., Wang, S. A., Chen, C. L., Hsu, F. L., Neoh, M. M., Lin, L. Y., Yuliani, F. S., Lin, C. H. & Chen, B. C., Jun 2024, In: Lung. 202, 3, p. 343-356 14 p.Research output: Contribution to journal › Article › peer-review
6 Citations (Scopus)
Datasets
-
Additional file 2 of Estradiol-mediated inhibition of Sp1 decreases miR-3194-5p expression to enhance CD44 expression during lung cancer progression
Young, M.-J. (Creator), Chen, Y.-C. (Creator), Wang, S.-A. (Creator), Chang, H.-P. (Creator), Yang, W.-B. (Creator), Lee, C.-C. (Creator), Liu, C.-Y. (Creator), Tseng, Y.-L. (Creator), Wang, Y.-C. (Creator), Sun, H. S. (Creator), Chang, W.-C. (Creator) & Hung, J.-J. (Creator), Figshare, 2022
DOI: 10.6084/m9.figshare.18517662.v1, https://springernature.figshare.com/articles/figure/Additional_file_2_of_Estradiol-mediated_inhibition_of_Sp1_decreases_miR-3194-5p_expression_to_enhance_CD44_expression_during_lung_cancer_progression/18517662/1
Dataset